Exercise Delays Progression of Early Parkinson's Disease: Study Findings
Just four hours of moderate exercise per week can significantly delay the progression of early Parkinson's disease, highlighting the potential therapeutic benefits of physical activity in managing this neurodegenerative condition.
October 2022
Psoriasis: Clinical Overview of a Heterogeneous Skin Disease
Psoriasis is a clinically heterogeneous skin disease that presents in multiple forms and locations, requiring individualized treatment approaches based on disease severity, phenotype, and patient-specific factors to achieve optimal management outcomes.
October 2022
Latin America: Mental Health of Healthcare Personnel at Risk
Despite the high prevalence of mental health issues among healthcare personnel in Latin America during the COVID-19 pandemic, only a third of those in need of psychological help received appropriate support, highlighting the urgent need for mental health resources and support services for frontline workers.
October 2022
Neurological Developmental Differences in Infants Born During the COVID-19 Pandemic
Being born during the COVID-19 pandemic is associated with differences in neurological development at 6 months of age, suggesting potential impacts of prenatal and early-life exposures on infant brain development and highlighting the need for further research to understand the long-term consequences.
October 2022
Congenital Pigmentary Anomalies in Neonates: Clinical Updates and Management
An update on manifestations, diagnosis, and treatment of neonatal congenital pigment anomalies provides valuable insights into the identification and management of these dermatological conditions in newborns, facilitating timely interventions and improved outcomes.
September 2022
Nobel Prize Winner Luc Montagnier's Legacy and Controversy
The passing of Nobel Prize winner Luc Montagnier sparks reflections on his contributions to science and his controversial involvement in pseudoscientific currents, highlighting the complexities of scientific legacy and the need for critical appraisal of scientific findings.
September 2022
Baricitinib Reduces Mortality in Severe COVID-19: Implications for Treatment
Baricitinib reduces the risk of death when administered to hospitalized patients with severe COVID-19, providing valuable therapeutic options to improve outcomes in critically ill individuals and mitigate the burden of COVID-19 mortality.
September 2022
Long COVID Prediction: Insights from Systems Biology
A study led by the Institute for Systems Biology identifies several warning factors for long COVID, providing insights into the underlying biological mechanisms and informing predictive models for identifying individuals at increased risk of persistent symptoms following SARS-CoV-2 infection.
September 2022
Long-Term Cardiovascular Outcomes of COVID-19: Implications for Follow-Up Care
Individuals with COVID-19 exhibit increased risks of incident cardiovascular disease at 12 months post-infection, highlighting the long-term cardiovascular consequences of SARS-CoV-2 infection and the need for comprehensive follow-up care to mitigate cardiovascular risk factors and prevent adverse outcomes.
September 2022
The Retinal Age Gap: Implications for Mortality Risk
The difference between the biological age of the retina and the individual's chronological age is associated with a higher risk of mortality, highlighting the potential utility of retinal age as a biomarker for predicting overall health and longevity.
September 2022
